Trade Summary

6 days ago, Kroeger Christopher A., serving as Chief Executive Officer at MapLight Therapeutics, Inc. (MPLT), sold 147,639 shares at $36.87 per share, for a total transaction value of $5,443,721.84. Following this transaction, Kroeger Christopher A. now holds 1,246,455 shares of MPLT.

This sale represents a 10.59% decrease in Kroeger Christopher A.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, July 15, 2026 and publicly disclosed via SEC Form 4 filing on Saturday, July 18, 2026 (accepted Jul 17, 9:46 PM ET), 3 days after the trade was made.

MapLight Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.